{"transactions":[{"id":3000323,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":145755,"kind":"person","name":"Colachis Arian","position":1,"cik":"0001807094","reported_name":"Colachis Arian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Common Stock","published_at":"2020-10-26T23:54:49.000Z","date":"2020-10-23","kind":"purchase","acquired":true,"shares":10000,"price":2.5,"value":25000.0,"ownership":{"direct":true},"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001807094-20-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000180709420000025/primary_doc.xml","form_type":"4"}},{"id":3017779,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":145755,"kind":"person","name":"Colachis Arian","position":1,"cik":"0001807094","reported_name":"Colachis Arian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Non-qualified Stock Option","published_at":"2020-10-03T00:41:49.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by a committee of the Issuer's Board of Directors on June 15, 2020, subject to stockholder approval of the Issuer's Amended & Restated 2012 Equity Incentive Plan (the \"Plan\") under which the option was granted. The Issuer's stockholders approved the Plan on September 30, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests annually in three equal installments beginning June 15, 2021."}],"balance_after":150000,"derivative":{"exercise_price":3.12,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001807094-20-000021","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000180709420000021/primary_doc.xml","form_type":"4"}},{"id":3017778,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":145755,"kind":"person","name":"Colachis Arian","position":1,"cik":"0001807094","reported_name":"Colachis Arian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Common Stock","published_at":"2020-10-03T00:41:49.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Amended & Restated 2012 Equity Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001807094-20-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000180709420000021/primary_doc.xml","form_type":"4"}},{"id":3203855,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":145755,"kind":"person","name":"Colachis Arian","position":1,"cik":"0001807094","reported_name":"Colachis Arian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-18T19:29:46.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three equal installments over a three-year period beginning March 16, 2021."}],"balance_after":200000,"derivative":{"exercise_price":0.96,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001807094-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000180709420000002/primary_doc.xml","form_type":"4"}}]}